Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,048 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,679 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01116245 | An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+(ADXS11-001) | terminated | Phase 2 | 81 | Advaxis, Inc.INDUSTRY | 1 | Jul 27, 2016 | clinicaltrials |
| NCT01481441 | Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer(AMC_2011_190) | terminated | N/A | 208 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 |
| Jul 6, 2016 |
| clinicaltrials |
| NCT00072215 | Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors | terminated | Phase 3 | 1 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 4, 2016 | clinicaltrials |
| NCT00861471 | Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | terminated | Phase 1 / Phase 2 | 24 | NYU Langone HealthOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT01003938 | Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer | terminated | Phase 2 | 6 | NYU Langone HealthOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT00003682 | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 3 | 160 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00003852 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | terminated | Phase 2 | 45 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT02140138 | An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer | terminated | Phase 2 | 35 | CureVacINDUSTRY | 1 | Jun 13, 2016 | clinicaltrials |
| NCT00503984 | A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients | terminated | Phase 1 / Phase 2 | 22 | University of MiamiOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT00671606 | Hysteroscopic Lymphatic Mapping for Endometrial Cancer | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | May 27, 2016 | clinicaltrials |
| NCT00216060 | Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy | terminated | Phase 3 | 63 | Christopher Sweeney, MBBSOTHER | 2 | May 26, 2016 | clinicaltrials |
| NCT00985738 | Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer | terminated | Phase 2 | 16 | University of Colorado, DenverOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT00529464 | Spectroscopy Versus Standard Care in Cervical Cancer Patients | terminated | Phase 3 | 2 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
| NCT01981707 | F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer(PRECHOL) | terminated | Phase 2 / Phase 3 | 12 | University Hospital, GrenobleOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT02749825 | Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | terminated | Phase 4 | 41 | PharmatechINDUSTRY | 1 | Apr 25, 2016 | clinicaltrials |
| NCT01832831 | Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy | terminated | — | 24 | University of MichiganOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT00243646 | Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | terminated | Phase 3 | 6 | Schiffler Cancer CenterOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02479178 | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck(iNSITE2) | terminated | Phase 2 | 73 | BIND TherapeuticsINDUSTRY | 2 | Apr 14, 2016 | clinicaltrials |
| NCT00024167 | Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | terminated | Phase 3 | 265 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT00447473 | Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer | terminated | Phase 2 | 31 | The Methodist Hospital Research InstituteOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT00448097 | Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy | terminated | Phase 2 | 7 | The Methodist Hospital Research InstituteOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT00450008 | Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer | terminated | Phase 2 | 9 | The Methodist Hospital Research InstituteOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT00521274 | Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer | terminated | Phase 2 | 11 | The Methodist Hospital Research InstituteOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT00521781 | Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | terminated | Phase 2 | 14 | The Methodist Hospital Research InstituteOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT01603420 | External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer | terminated | Phase 2 / Phase 3 | 2 | Proton Collaborative GroupNETWORK | 1 | Mar 14, 2016 | clinicaltrials |
| NCT01675011 | Embozene Microspheres for Uterine Fibroid Embolization (UFE) | terminated | N/A | 4 | Boston Scientific CorporationINDUSTRY | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00526799 | Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer | terminated | Phase 1 / Phase 2 | 30 | Daniela Matei, MDOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT01220427 | Micro-RNA Expression Profiles in High Risk Prostate Cancer | terminated | — | 300 | Wuerzburg University HospitalOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT00522301 | Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission | terminated | Phase 2 | 6 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 29, 2016 | clinicaltrials |
| NCT00122265 | Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer | terminated | — | 83 | AHS Cancer Control AlbertaOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT00523471 | Blood Test to Measure DNA Damage in Blood | terminated | — | 40 | AHS Cancer Control AlbertaOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT01292733 | Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer(OCEDP) | terminated | Early Phase 1 | 534 | Swedish Medical CenterOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT00718523 | Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer | terminated | Phase 2 | 170 | Translational Research in OncologyOTHER | 8 | Jan 12, 2016 | clinicaltrials |
| NCT00250757 | Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions | terminated | — | 101 | New Mexico Cancer Research AllianceOTHER | 1 | Jan 8, 2016 | clinicaltrials |
| NCT00734851 | Multimodality Phase II Study in Prostate Cancer | terminated | Phase 2 | 36 | Duke UniversityOTHER | 1 | Dec 23, 2015 | clinicaltrials |
| NCT01840943 | A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | terminated | Phase 3 | 32 | Xian-Janssen Pharmaceutical Ltd.INDUSTRY | 1 | Dec 23, 2015 | clinicaltrials |
| NCT00932672 | Atkins Diet and Prostate Cancer Clinical Trial | terminated | Phase 2 | 45 | Duke UniversityOTHER | 1 | Dec 7, 2015 | clinicaltrials |
| NCT00381836 | Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer | terminated | Phase 2 / Phase 3 | 140 | University of AarhusOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT02139774 | Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer | terminated | — | 15 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT00313612 | Oxaliplatin and Topotecan in Advance Ovarian Cancer | terminated | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Nov 27, 2015 | clinicaltrials |
| NCT00596544 | Sexual Functioning After Primary Treatment of Ovarian Cancer | terminated | — | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 26, 2015 | clinicaltrials |
| NCT02024685 | Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial | terminated | N/A | 76 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 10, 2015 | clinicaltrials |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | terminated | Phase 1 / Phase 2 | 79 | Otsuka Novel Products GmbHINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00629330 | Dissemination of Prostate Cancer Screening to PCP's in African American Communities | terminated | Phase 4 | 86 | Columbia UniversityOTHER | 0 | Oct 14, 2015 | clinicaltrials |
| NCT01175967 | Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer | terminated | — | 11 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT00585416 | Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer | terminated | Phase 2 | 23 | University of Wisconsin, MadisonOTHER | 1 | Oct 2, 2015 | clinicaltrials |
| NCT00288106 | S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT | terminated | — | 961 | SWOG Cancer Research NetworkNETWORK | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00899132 | Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer | terminated | — | 180 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00758732 | Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma | terminated | Phase 2 | 34 | Hellenic Oncology Research GroupOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT02185170 | DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections | terminated | N/A | 5 | University Hospital, GrenobleOTHER | 1 | Sep 22, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Jul 27, 2016source: clinicaltrials